Recent Quarter Total Invested
$18.02 M
Recent Quarter Institutional Ownership Percentage
25.9%
Total Invested of Last Quarter
$23.64 M
Ownership Percentage of Last Quarter
26.07%
Spero Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ANSON FUNDS MANAGEMENT LP | 08/13/2024 | 3.75 M | $4.88 M | 0.00% | 7.01% |
VANGUARD GROUP INC | 08/13/2024 | 1.77 M | $2.30 M | 7.08% | 3.31% |
ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 1.07 M | $1.39 M | 40.55% | 2.00% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 975,952 | $1.27 M | 14.22% | 1.82% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 918,929 | $1.19 M | -0.86% | 1.72% |
ALPHABET INC. | 08/02/2024 | 889,979 | $1.16 M | 0.00% | 1.66% |
MURCHINSON LTD. | 08/15/2024 | 873,910 | $1.14 M | 0.00% | 1.63% |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 08/09/2024 | 535,336 | $695,937 | -11.90% | 1.00% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 492,187 | $639,993 | 4.85% | 0.92% |
BLACKROCK INC. | 08/13/2024 | 483,402 | $628,423 | 1.36% | 0.90% |
NOVO HOLDINGS A/S | 08/20/2024 | 468,902 | $609,573 | 0.00% | 0.88% |
AWM INVESTMENT COMPANY, INC. | 08/14/2024 | 333,400 | $433,420 | 0.00% | 0.62% |
CITADEL ADVISORS LLC | 08/14/2024 | 312,034 | $405,644 | 100.00% | 0.58% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 184,800 | $240,240 | 0.00% | 0.35% |
STATE STREET CORP | 08/14/2024 | 130,511 | $169,664 | 0.00% | 0.24% |
DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 125,000 | $162,500 | 0.00% | 0.23% |
NORTHERN TRUST CORP | 08/14/2024 | 112,303 | $145,994 | -1.97% | 0.21% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 98,518 | $128,073 | -33.38% | 0.18% |
MAN GROUP PLC | 08/14/2024 | 73,469 | $95,510 | -65.67% | 0.14% |
TWO SIGMA SECURITIES, LLC | 08/14/2024 | 67,728 | $88,046 | 100.00% | 0.13% |
MACKENZIE FINANCIAL CORP | 08/14/2024 | 32,729 | $42,548 | 15.07% | 0.06% |
DLK INVESTMENT MANAGEMENT, LLC | 08/05/2024 | 31,355 | $40,762 | 0.00% | 0.06% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 28,565 | $37,135 | 0.00% | 0.05% |
SHAY CAPITAL LLC | 08/14/2024 | 25,000 | $32,500 | -91.86% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 23,073 | $29,995 | 100.00% | 0.04% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 10,003 | $13,004 | 0.00% | 0.02% |
TEXAS YALE CAPITAL CORP. | 08/13/2024 | 10,000 | $13,000 | 0.00% | 0.02% |
MORGAN STANLEY | 10/17/2024 | 6,971 | $9,062 | -11.75% | 0.01% |
RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 6,400 | $8,320 | 0.00% | 0.01% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 5,558 | $7,225 | 7.05% | 0.01% |
FMR LLC | 08/13/2024 | 2,889 | $3,756 | 20.93% | 0.01% |
WR WEALTH PLANNERS, LLC | 07/31/2024 | 2,600 | $3,380 | 0.00% | 0.00% |
CULLEN/FROST BANKERS, INC. | 08/05/2024 | 2,000 | $2,600 | 100.00% | 0.00% |
ROYAL BANK OF CANADA | 08/14/2024 | 1,959 | $3,000 | 100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 1,000 | $1,300 | 85.19% | 0.00% |
CITADEL ADVISORS LLC | 08/14/2024 | 1,000 | $1,300 | 100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 07/24/2024 | 600 | $840 | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 08/14/2024 | 500 | $650 | 100.00% | 0.00% |
RHUMBLINE ADVISERS | 08/01/2024 | 458 | $595 | 0.00% | 0.00% |
UBS GROUP AG | 08/14/2024 | 331 | $430 | -94.22% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 295 | $384 | 527.66% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 276 | $359 | 27.78% | 0.00% |
JPMORGAN CHASE & CO | 08/12/2024 | 236 | $307 | 0.00% | 0.00% |
CORECAP ADVISORS, LLC | 08/08/2024 | 192 | $250 | 35.21% | 0.00% |
US BANCORP \DE\ | 08/07/2024 | 151 | $196 | 0.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 08/16/2024 | 100 | $130 | 0.00% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2024 | 30 | $39 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 12 | $16 | 0.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 1 | $1 | 0.00% | 0.00% |
BAILARD, INC. | 07/25/2024 | 0 | $0 | -100.00% | 0.00% |
Spero Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of SPRO shares?
During the previous two years, 62 institutional investors and hedge funds held shares of Spero Therapeutics, Inc.. The most heavily invested institutionals were:
Allworth Financial LP: 0
Anson Funds Management LP: 3.75 M
VANGUARD GROUP INC: 1.77 M
ACADIAN ASSET MANAGEMENT LLC: 1.07 M
RENAISSANCE TECHNOLOGIES LLC: 975,952
ADAR1 Capital Management, LLC: 918,929
-
What percentage of Spero Therapeutics, Inc. stock is owned by institutional investors?
25.90% of Spero Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at SPRO ?
Institutional investors have bought a total of 16.88 M shares in the last 24 months. This purchase volume represents approximately $22.45 M in transactions.